Business Description
Shoulder Innovations Inc
NAICS : 339112
SIC : 3841
ISIN : US82537J1088
Total Employee Number:
75Description
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System. Geographically, the company operates in United States and are planning to expand.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 7.23 | |||||
Equity-to-Asset | 0.83 | |||||
Debt-to-Equity | 0.11 | |||||
Debt-to-EBITDA | -0.36 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 9.87 | |||||
Beneish M-Score | -2.04 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 26.79 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 30.63 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 85.39 | |||||
9-Day RSI | 80.14 | |||||
14-Day RSI | 76.45 | |||||
3-1 Month Momentum % | 1.63 | |||||
6-1 Month Momentum % | -3.1 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 11.81 | |||||
Quick Ratio | 10.04 | |||||
Cash Ratio | 8.8 | |||||
Days Inventory | 543.07 | |||||
Days Sales Outstanding | 53.31 | |||||
Days Payable | 188.48 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -0.04 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 76.81 | |||||
Operating Margin % | -57.48 | |||||
Net Margin % | -81.78 | |||||
EBITDA Margin % | -76.63 | |||||
FCF Margin % | -81.22 | |||||
OCF Margin % | -63.98 | |||||
ROE % | -77.58 | |||||
ROA % | -34.25 | |||||
ROIC % | -102.8 | |||||
ROC (Joel Greenblatt) % | -155.66 | |||||
ROCE % | -38.61 | |||||
Moat Score | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 7.82 | |||||
PB Ratio | 3.55 | |||||
Price-to-Tangible-Book | 3.55 | |||||
EV-to-EBIT | -8.43 | |||||
EV-to-EBITDA | -9.18 | |||||
EV-to-Revenue | 7.03 | |||||
EV-to-FCF | -8.66 | |||||
| Price-to-Net-Current-Asset-Value | 3.99 | |||||
| Price-to-Net-Cash | 5.81 | |||||
Earnings Yield (Greenblatt) % | -11.86 | |||||
FCF Yield % | -9.27 |
GF Valueâ„¢
Shoulder Innovations Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shoulder Innovations Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-11 16:30 | In 137 days | ||
| Third quarter earnings results for 2026 | 2026-11-11 | In 136 days | ||
| Second quarter earnings results for 2026 | 2026-09-09 | In 73 days | ||
| General meeting for 2026 | 2026-06-26 15:00 | 17.20 (+0.00%) | ||
| Goldman Sachs 47th Annual Global Healthcare Conference | 2026-06-09 | 12.20 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-05-13 16:30 | 11.00 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-13 | 11.00 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-10 16:30 | 11.10 (+0.00%) | ||
| Annual report for 2025 | 2026-03-10 | 11.10 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-10 | 11.10 (+0.00%) |
Show
Entries
Press Release
Articles on Shoulder Innovations Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers